ARL8B lysosomal ,

Liyan Wu1,2, Zelin Weng1,2, Xia Yang1,2

  • 1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China.

Scientific reports
|April 10, 2025
PubMed
概括

在肝癌中,氨酸5'-二酸二酸核糖化因子类8B (ARL8B) 的含量升高,通过破坏 lysosomes,导致预后不佳. 向ARL8B可能会改善肝细胞癌 (HCC) 的治疗反应.